Interactions between EV‐A71 proteins and the human receptor SCARB2 and the human receptor SCARB2 using molecular docking and molecular dynamics simulations under balanced, electrostatic, hydrophobic, and VdW+Elec conditions are examined to reveal key EV‐A71–SCARB2 interaction mechanisms.
Abstract
Enterovirus A71 (EV‐A71) is a major cause of hand, foot, and mouth disease and is linked to severe neurological complications in children. No approved antiviral therapy is currently available, and vaccine coverage remains limited, highlighting the need for new therapeutics. This study examined interactions between EV‐A71 proteins (VP0, VP1‐VP4, and 3C protease) and the human receptor SCARB2 using molecular docking and molecular dynamics (MD) simulations under balanced, electrostatic, hydrophobic, and VdW+Elec conditions. Among all complexes, SCARB2‐VP3 showed the highest stability, with hydrophobic‐favored scores of −1358.8/−1650.1 (70 members), balanced (−994.7/−1251.3; 59 members), electrostatic‐favored (−987.3/−1069.8; 69 members), and VdW+Elec (−165.0/−201.6), indicating consistently strong affinity. MD results showed that in the balanced system SCARB2‐VP3 had RMSD 1.47 ± 1.42 nm, RMSF 1.60 ± 0.72 nm, Rg 3.44 ± 0.91 nm, and 25 H‐bonds. In electrostatic conditions, it showed RMSD 3.25 ± 1.33 nm and Rg 4.61 ± 0.89 nm. Under hydrophobic mode, it remained compact (Rg 3.82 ± 0.81 nm) with 17 H‐bonds. In VdW+Elec, it showed RMSD 1.04 ± 0.70 nm, RMSF 0.92 ± 0.36 nm, and Rg 3.19 ± 0.52 nm. Cross‐docking confirmed binding to PSGL‐1 (3O2U), ICAM‐1 (1IC1), and DAF/CD55 (1H03). These findings reveal key EV‐A71–SCARB2 interaction mechanisms.
Docking analysis identified two lead compounds that favorably occupied the catalytic pocket and formed stabilizing interactions with key residues, including His40, Glu71, and Cys147, in comparison with the reference inhibitor rupintrivir as promising non-covalent HRV 3Cpro inhibitor candidates for further experimental...
The SARS‐CoV‐2 nucleocapsid (N) protein is a key regulator of viral genome packaging and replication, making it an attractive antiviral target. Here, we provide structural and energetic insights into N‐protein inhibition using molecular docking, pharmacophore screening, molecular dynamics (MD) simulations, and MM‐PBS...
Srimai Vuppala, Jaeyoung Kim, Mengdi Zhao et al.· Bulletin of the Korean Chemi...· 0 citations
The results of this study highlight the significant advantages of J27820 and J22352, emphasizing their potential for targeted inhibition and promising opportunities for developing effective antiviral therapies against the Zika virus.
Farid Elbamtari, Etibaria Belghalia, Mhamed Elbouhi et al.· Fabad journal of pharmaceuti...· 0 citations
A protein-protein interaction network from the genes associated with the dengue infection was constructed and proteins were ranked by the topological centrality to identify hub regulators and validated POLR2A and ELOC as hub genes in the transcriptional regulation network associated with dengue.
S. M. Zaidh, M. H. Mohamed Asrarullah, Kathiravan Muthukumaradoss et al.· Journal of Pharmaceutical In...· 0 citations
The high mutation rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) may alter viral protein structures and reduce the effectiveness of vaccines that primarily target the spike (S) protein. The nucleocapsid (N) protein is highly conserved and immunogenic, making it a promising alternative antigen for...
Wenny Maylina Mulyo Tjahyani, Surya Rosa Putra, Devy Maulidya Cahyani et al.· EPJ Web of Conferences· 0 citations
This work demonstrates the utility of MD-driven contact network analysis and clustering approaches in uncovering conserved interfacial motifs and adaptive strategies, providing a computational framework for monitoring and interpreting the molecular evolution of emerging SARS-CoV-2 variants.
Linh Truong Hoai· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.